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Abstract  The  endobronchial  ultrasound  (EBUS)  scope  has  been  increasingly  used  in  the  gas-
trointestinal  tract  (EUS-B).  Scientific  data  proves  its  efficacy  and  safety  to  provide  a  complete
lung cancer  staging,  when  combined  with  EBUS-TBNA,  and  in  the  diagnosis  of  para-esophageal
lesions. There  are  multiple  barriers  to  start  performing  EUS-B  but  probably  the  most  important
ones are  related  to  knowledge  and  training,  so  new  operators  should  follow  a  structured  training
curriculum.  This  review  aims  to  reflect  the  best  current  knowledge  regarding  EUS-B  and  provide
a road  map  to  assist  those  who  are  incorporating  the  technique  into  their  clinical  practice.Non-small-cell  lung
cancer;
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ntroduction
he  development  of  the  endobronchial  ultrasound  (EBUS)
cope  and  its  incorporation  into  clinical  practice  was  a
reakthrough  in  XXI  century  respiratory  medicine.  A  sim-
le  and  elegant  procedure,  it  has  permitted  safe  diagnosis
nd/or  staging  of  pulmonary  and  mediastinal  disease,  avoid-
ng  more  invasive  and  costly  exams.
As  knowledge  grew,  new  indications  arose  and  experi-
nced  centers  published  data  concerning  the  combined  use
f  EBUS  and  EUS  (endoscopic  ultrasound  through  the  esopha-
us)  needle  aspiration  (NA)  to  correctly  stage  non-small  cell
ung  cancer  patients.1,2 Although  successful,  this  approach
ad  several  limitations  as  it  required  a  proficient  endo-
copist  --  initially  only  a  small  group  of  chest  physicians
orldwide  had  enough  expertise  to  use  the  EUS  scope  --  ded-
cated  equipment,  additional  time  and  sometimes  different
ettings,  which  taken  all  together  contributed  to  increased
osts  and  to  delayed  implementation.
Successful  transesophageal  and  gastric  use  of  the  EBUS
cope  (EUS-B)  was  first  reported  in  2007.3 In  2010,  two  land-
ark  papers  proved  that  the  dual  use  of  EBUS,  through  the
racheal-bronchial  tree  and  the  esophagus  was  feasible  and
ould  be  performed  sequentially  in  the  same  setting,  by  one
perator  and  with  a  high  diagnostic  yield  for  lung  cancer
taging.4,5 This  strategy  has  shown  that,  potentially,  most
f  the  previous  limitations  can  be  overcome.  These  publica-
ions  were  soon  followed  by  certification  for  EBUS  scopes  to
e  used  in  the  upper  gastrointestinal  tract.
In  the  last  few  years,  EBUS  has  disseminated  from  aca-
emic  centers  to  community-based  hospitals  and  is  now  an
mportant  equipment  in  most  bronchoscopy  units.  Gradu-
lly,  more  chest  physicians  are  also  inserting  the  EBUS  scope
nto  the  esophagus  due  to  its  advantages  and  encouraged
y  their  familiarity  with  the  equipment.  EUS-B-NA  makes
 more  complete  assessment  of  the  mediastinum  possible
hen  added  to  EBUS-TBNA.  It  provides  nearly  complete
ccess  to  all  relevant  lymph  nodes  for  staging  lung  can-
er;  permits  the  diagnosis  of  para-esophageal  mediastinal
nd  lung  lesions  which  cannot  be  accessed  through  the
racheo-bronchial  tree;  permits  access  to  the  lower  medi-
stinal  lymph  node  stations  (e.g.  stations  8  and  9)  and
ub-diaphragmatic  lymph  nodes;  and  in  comparison  to  EBUS
t  may  offer  an  easier  alternative  for  puncturing  challenging
ymph  nodes  in  certain  patients  (e.g.  stations  2L  and  4L).
dditionally,  EUS-B-NA  is  usually  a  well-tolerated  procedure
nder  conscious  sedation,  achieved  by  lower  doses  of  seda-
ives  and  anesthetics  and  is  associated  with  less  cough  and
xygen  desaturation  when  compared  to  EBUS,  which  is  an
mportant  consideration  in  patients  with  compromised  lung
unction.6
Nevertheless,  there  are  multiple  barriers  to  starting  per-
orming  EUS-B-NA  and  the  most  important  ones  are  related
o  knowledge  and  training.  A  few  publications  provide
nstructions  on  how  to  perform  EUS  but  they  are  not  ded-
cated  to  EUS-B.7--9 The  present  review  aims  to  reflect  the
est  current  knowledge  regarding  this  technique,  focus-Please  cite  this  article  in  press  as:  Bugalho  A,  et  al.  Pulmonol.
ng  on  recent  guidelines,  and  to  provide  a  road  map  to
ssist  those  who  want  to  integrate  EUS-B  into  their  clinical
ractice.
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hen to do EUS-B?
alignant  diseases
ung  cancer
egarding  the  correct  diagnosis  and  staging  of  lung  can-
er  patients,  tissue  confirmation  is  still  mandatory  to  select
he  best  therapy  and  to  enhance  outcomes.10 In  addition,
nlarged  lymph  nodes  in  the  mediastinum  and/or  the  pul-
onary  hilum  are  always  suspicious  for  malignancy  and
equire  further  evaluation.
Histological  biopsies  obtained  by  mediastinoscopy  have
een  the  diagnostic  gold  standard  for  a  long  time  but  this
urgical  approach  is  invasive  and  associated  with  morbid-
ty  and  additional  costs.11,12 Therefore,  minimally  invasive
echniques  have  been  developed.  EUS-NA,  the  endoscopic
ampling  of  cytological  specimens  from  the  mediastinum
hrough  the  esophagus,  is  the  older  technique,  largely  per-
ormed  by  gastroenterologists.  With  the  EUS-scope  the  left
ediastinum  and  the  upper  part  of  the  abdomen  can  be
ssessed.  In  contrast,  EBUS  provides  an  endoscopic  access
o  the  upper  mediastinal  and  the  hilar  lymph  node  stations,
ut  distal  paraesophageal  lymph  nodes  or  structures  below
he  diaphragm  cannot  be  reached  via  the  endobronchial  way.
oth  techniques  represent  a  valuable  alternative  to  surgical
taging  (Fig.  1).
The  accuracy  of  EUS-NA  and  EBUS-TBNA  for  evaluat-
ng  mediastinal  lymph  node  metastasis  has  been  assessed
n  several  clinical  trials.  In  meta-analyses  concerning  this
ndication,  the  pooled  sensitivity  for  EBUS-TBNA  was  93%,
hereas  a  sensitivity  of  83%  for  EUS-NA  was  reported.13,14
urthermore,  in  numerous  studies  it  has  been  shown  that
he  diagnostic  value  of  a  combined  EBUS/EUS  procedure
as  superior  to  either  EBUS-TBNA  or  EUS-NA  techniques
lone,  but  no  randomized  controlled  trials  comparing  these
ttempts  had  been  performed  yet  4.15,16
In  a randomized  controlled  study,  comparing  immedi-
te  surgical  staging  to  endoscopic  staging,  the  combined
ndosonography  approach  with  EBUS  and  EUS  was  superior  to
ediastinoscopy.  The  sensitivity  for  lymph  node  metastasis
as  79%  for  surgical  staging  versus  85%  for  endosonography
ithout  subsequent  surgical  staging.17 Current  international
uidelines  therefore  recommend  the  endoscopic  needle
echniques  over  surgical  staging  as  the  first  test  for  medi-
stinal  staging  in  lung  cancer  patients.11,18,19
As  previously  mentioned,  in  two  studies  published  simul-
aneously,  both  EBUS-TBNA  and  EUS-B-NA  were  performed
n  patients  with  suspected  lung  cancer  for  diagnosing  and
taging.4,5 The  sensitivity  for  EBUS-TBNA  was  91.5%  and
4.4%  respectively.  Sensitivity  for  EUS-B-NA  alone  was  88.7%
n  one  trial.  For  the  combined  approach  of  EBUS-TBNA  plus
US-B-NA  the  sensitivity  rose  to  more  than  90%  in  both  trials.
mportantly,  the  negative  predictive  value  for  malignancy
sing  combination  of  EBUS  and  EUS-B  was  96%  in  both  trials.
articularly  high  negative  predictive  value  for  malignancy
ay  in  the  future  reduce  the  need  for  surgical  confirma-
ion,  when  the  results  of  the  needle  acquired  specimens  are
egative  for  malignant  cells. 2018.  https://doi.org/10.1016/j.rppnen.2017.10.004
The  utility  of  the  EBUS-scope  for  performing  EUS-B-NA
n  the  same  setting  was  confirmed  in  a further  publication.
n  this  prospective  study,  123  patients  with  undiagnosed
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Figure  1  (  a)  56-year-old  patient  with  a  PET-positive  pulmonary  tumor  in  the  left  upper  lobe  suspicious  of  primary  lung  cancer
(TU). In  lymph  node  station  7  (LN7)  there  is  increased  FDG-uptake;  (b)  EBUS  image  of  the  lymph  node  in  station  7;  (c)  corresponding
EUS-B image  of  the  same  lymph  node  from  esophagus  with  the  same  bronchoscope;  (d)  cytological  image  of  the  EUS-B-NA  showing
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cadenocarcinoma  cells  with  background  blood  (courtesy  of  Cynth
but  suspected  malignant  lung  lesions  were  assessed  by
both  EBUS-TBNA  and  EUS-B-NA  after  at  least  one  non-
diagnostic  conventional  procedure.20 A  definitive  diagnosis
was  obtained  in  87.6%  of  these  patients  and  the  diagnos-
tic  accuracy  was  90.1%.  In  addition,  the  authors  provided
evidence  that  the  combined  use  of  the  bronchoscope  for
EBUS-TBNA  and  EUS-NA  enabled  omission  of  surgical  proce-
dures  and  significantly  reduced  costs.
In  a  recently  published  meta-analysis,  the  overall  diag-
nostic  yield  of  EUS-B-NA  combined  with  EBUS-TBNA  was
estimated.21 More  than  1  000  subjects  were  included  and
the  sensitivity  of  the  combined  procedure  was  significantly
higher  than  for  EBUS-TBNA  alone  (91%  vs.  80%;  p  =  0.004).
The  additional  diagnostic  gain  of  EUS-B-NA  over  EBUS-TBNA
was  7.6%.  The  authors  calculated  that  10  combined  proce-
dures  were  needed  to  achieve  one  additional  diagnosis,  as
compared  with  EBUS-TBNA  alone.
Other  indications  for  EUS-B  in  malignancy
Intrapulmonary  tumors  located  adjacent  to  the  mediasti-
nal  pleura  are  usually  visible  by  endosonography.  For  that
reason,  EBUS  as  well  as  EUS  are  useful  tools  in  diagnosing
these  pulmonary  lesions  in  adults  and  children22--24 (Fig.  2).Please  cite  this  article  in  press  as:  Bugalho  A,  et  al.  Pulmonol.
In  a  prospective  trial,  the  feasibility  of  diagnosing  intrapul-
monary  lesions  by  EUS-B-NA  was  demonstrated.  In  addition,
the  authors  could  confirm  EGFR  mutation  and  ALK  fusion
gene  in  some  patients.25
L
p
dn  der  Horst,  MD,  Glasgow,  UK).
Mediastinoscopy  has  been  used  to  restage  after  neoadju-
ant  therapy  and  for  the  assessment  of  tumor  recurrence
fter  previous  thoracic  surgery.  Still,  this  procedure  is
echnically  more  difficult,  less  safe,  and  less  useful  for
estaging.  Besides,  the  evidence  exists  that  EBUS-TBNA  and
US-NA  can  deliver  comparable  results.26,27 In  a  prospec-
ive  study,  106  patients  have  been  included  after  induction
herapy  for  restaging.28 They  were  assessed  by  both  EBUS
nd  EUS  using  the  same  bronchoscope.  In  286  biopsied
ymph  node  stations,  the  total  accuracy  was  81.0%  and
he  yield  for  the  combined  approach  was  higher  com-
ared  with  EBUS-TBNA  or  EUS-B-NA  alone.  In  another
ublication,  the  authors  confirmed  loco-regional  tumor
ecurrence  by  EUS-B-NA  in  cases  where  EBUS-TBNA  was  not
ossible.29
Puncturing  the  left  adrenal  gland  (LAG)  with  an  EUS-
astroscope  is  a  well-established  technique  to  confirm
ntra-abdominal  metastasis.19,30,31 This  is  also  possible  with
he  EUS-B  scope  to  assess  and  puncture  the  LAG  endoscop-
cally  (Fig.  3). In  a  prospective  multicenter  trial,  adequate
issue  sampling  was  feasible  in  93%  with  the  EUS-scope  and
n  89%  with  EUS-B-NA  in  patients  with  suspected  metastasis
f  the  LAG.32 However,  despite  these  encouraging  reports,
urrently  the  use  of  the  EBUS  bronchoscope  for  sampling  the 2018.  https://doi.org/10.1016/j.rppnen.2017.10.004
AG  is  not  generally  recommended.19
Finally,  EUS-B  may  be  used  as  an  initial  procedure  for
atients  with  suspected  mediastinal  lymphoma  since  it  may
ecrease  the  need  for  more  invasive  approaches  but  sen-
ARTICLE IN+ModelPULMOE-1293; No. of Pages 10
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Figure  2  82-year-old  patient  with  a  solid  lung  lesion  in  the
right upper  lobe  (a).  The  lesion  was  assessed  by  EUS-B-NA  (b).
Final diagnosis  was  lung  adenocarcinoma  EGFR  positive.
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Figure  3  EUS-B  image  of  an  enlarged  left  adrenal  gland.  The
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sonography  console),  characteristics  of  the  EBUS  scopedjacent  kidney  is  visible  at  the  right  lower  corner  (K).
itivity  for  final  diagnosis  and  subtyping  varies  widely  in
ifferent  case-series.
enign  diseasesPlease  cite  this  article  in  press  as:  Bugalho  A,  et  al.  Pulmonol.
nly  a  few  studies  were  published  using  EUS-B  in  non-
alignant  diseases.
(
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A.  Bugalho  et  al.
In  clinical  practice,  most  patients  with  suspected  sar-
oidosis  present  stage  I  or  II  disease,  characterized  by
ncreased  lymph  nodes.  Current  diagnosis  of  pulmonary  sar-
oidosis  is  shifting  from  conventional  flexible  bronchoscopy
ith  accessory  techniques  to  other  minimally  invasive  tech-
iques,  with  improved  efficacy  and  safety.  In  recent  years,
he  detection  of  non-caseating  granulomas  in  mediastinal
ymph  nodes  was  easily  performed  by  EBUS-TBNA  or  EUS-
A.33,34 In  a 2013,  Oki  et  al.  used  EUS-B-NA  in  33  patients  to
iagnosis  stage  I/II  sarcoidosis.35 They  achieved  a  diagnostic
ield  of  86%  without  complications.
In  other  retrospective  studies,  EUS-B-NA  allowed  the
iagnosis  of  tuberculosis  lymphadenitis  in  both  chil-
ren  and  adults,  during  the  differential  diagnosis  of
ediastinal  or  hilar  lymphadenopathies.24,36 In  these  situa-
ions,  the  diagnostic  yield  increases  if  samples  are
ent  simultaneously  for  microbiology,  cytopathology,  and
ycobacterium  tuberculosis-polymerase  chain  reaction.37
ow to do EUS-B?
ettings  and  equipment
here  are  no  specific  recommendations  for  EUS-B  regarding
inimal  room  and  equipment  requirements  hence  they  are
xtrapolated  from  conventional  bronchoscopy  and  EBUS
uidelines.
In  most  cases,  EUS-B  can  be  safely  done  as  an  outpatient
rocedure  in  a bronchoscopy  unit.  The  suite  should  be  prop-
rly  equipped  for  patient  monitoring.  A  secure  intravenous
ccess  is  mandatory  and  specific  anesthetic  drugs  should  be
t  hand.  Oxygen  delivery  systems  and  resuscitation  equip-
ent  should  also  be  readily  available.38 The  procedure  is
sually  performed  under  moderate  or  deep  sedation  to
chieve  appropriate  patient  comfort  and  collaboration.39 In
ome  cases,  depending  on  local  settings,  the  goal  of  the  pro-
edure  (systematic  staging  vs.  targeted  diagnostic  puncture)
nd  the  operator’s  experience,  general  anesthesia  may  be  a
alid  option.
A  certified  bronchoscopist  with  formal  endosonography
raining,  two  nurses  --  one  to  assist  during  the  procedure
nd  other  dedicated  to  sedation  --  and  an  anesthesiologist,
n  case  of  deep  sedation  or  general  anesthesia,  should  be  the
inimal  personnel  requirements  to  perform  the  procedure
ecurely.
The  presence  of  a  cytopathologist  for  rapid  on-site  eval-
ation  (ROSE)  does  not  seem  to  affect  the  diagnostic  yield,
ut  reduces  the  number  of  punctures,  procedure  time  and
an  be  useful  to  evaluate  the  quality  of  material  and  quan-
ity  of  malignant  cells,  namely  when  molecular  testing  is
lanned.39
In  terms  of  equipment,  different  electronic  linear  scan-
ing  echoendoscopes  are  commercially  available  (Table  1).
hen  deciding  which  one  to  choose,  several  factors  need
o  be  considered,  including  the  existence  of  compatible
quipment  already  available  (e.g.  video  processors,  ultra- 2018.  https://doi.org/10.1016/j.rppnen.2017.10.004
direction  of  view,  flexibility,  distal  end  size,  diameter  of
he  working  channel,  video  quality  and  ultrasonic  image),
s  well  as  costs  and  post-vending  manufacture  assistance.
Please  cite  this  article  in  press  as:  Bugalho  A,  et  al.  Pulmonol.
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he  final  decision  depends  on  a  compromise  between  these
ptions.
Multiple  disposable  needles  are  available,  all  devel-
ped  on  the  basis  of  the  original  construction  of  the
ancke-Vilmann  needle  system  (GIP-Medizin  Technik  now
edi-Globe):  a  long-steel  needle,  a  sheath  and  a  handle
or  manipulation.40 Technological  advancements  have  led  to
xperimentation  of  new  designs  and  materials  that  improve
andling  and  performance  but  increase  costs.  Even  though
he  main  principles  are  the  same,  needles  differ  in  several
haracteristics  (Table  2).  There  are  no  prospective  compara-
ive  studies  showing  the  superiority  of  one  needle39 over  the
thers,  so  the  operator  needs  to  consider  the  handle  design
ergonomic  and  maneuverability)  and  the  characteristics  of
eedle  ‘‘per  se’’  (durability,  flexibility,  echogenicity).  Other
eatures  are,  compatibility  with  the  equipment  and  costs,
specially  if  we  aim  for  a  needle  that  provides  histolog-
cal  core  samples  (e.g.  Vizishot  Flex
®
,  Echotip  Procore
®
).
ccording  to  recent  guidelines,  the  operator  should  deter-
ine  needle  choice  and  either  21G  or  22G  are  acceptable
ptions  for  most  cases.39
tep-by-step
he  EUS-B  scope  is  inserted  through  the  mouth  into  the
sophagus  gently  rotating  it  with  a  screw  movement,  and
dvanced  under  visual  control  to  the  gastric  fundus.  While
ntroducing  the  scope,  suction  should  be  used  only  in  an
ntermittent  manner,  to  avoid  deflating  the  esophageal  tract
ompletely.  The  endoscopic  view  is  not  normally  useful  and
ndosonography  scanning  guides  the  procedure.  From  this
oment  on,  continuous  suction  is  mandatory  to  facilitate
he  contact  between  the  ultrasound  transducer  and  the
sophageal  wall.  At  the  cardia  region,  the  transducer  is
urned  back  until  the  abdominal  aorta  is  clearly  visualized
n  its  longitudinal  diameter  (Fig.  4).  To  identify  the  LAG,
he  tip  of  the  bronchoscope  is  slid  down  the  aorta,  up  to
he  celiac  trunk  and  mesenteric  artery,  which  are  the  first
essels  extending  from  the  abdominal  aorta.  At  this  point,
he  EUS-B  scope  is  turned  counterclockwise  (if  the  physi-
ian  is  standing  behind  a  patient  lying  in  supinal  position
his  movement  turns  the  transducer  to  the  left)  to  visual-
ze  the  left  kidney,  the  spleen,  and  the  LAG  just  behind
he  celiac  trunk  and  mesenteric  artery.  After  seeing  the
AG,  the  transducer  is  brought  back  to  its  standard  neu-
ral  position  at  the  cardia.  In  front,  the  left  lobe  of  the
iver,  diaphragm  and  heart  are  clearly  visualized  (Fig.  4A),
nd  to  the  right  the  hepatic  veins  can  be  followed  as  they
pproach  the  inferior  vena  cava.  Then  scanning  proceeds
y  withdrawing  the  transducer  to  the  distal  esophagus.  The
US-B  scope  is  turned  around  from  the  descending  aorta
nd  back  to  the  aorta  again  (Fig.  4B),  visualizing  retroperi-
oneal  and  para-aortic  lymph  nodes.  If  the  scope  is  turned
lightly  more  to  the  left,  the  diaphragm  is  clearly  seen  on  the
eft  corner  and  the  right  atrium  on  the  right.  At  this  level,
he  left  pulmonary  ligament  lymph  nodes  (station  9)  can  be
etected.  During  further  withdrawal  of  the  scope,  from  the 2018.  https://doi.org/10.1016/j.rppnen.2017.10.004
istal  to  the  middle  part  of  the  esophagus,  para-esophageal
station  8)  and  lower  para-aortic  lymph  nodes  are  seen  pos-
eriorly.  Then  the  heart  is  visualized  anteriorly,  with  the  left
entricle  coming  first  into  focus,  at  that  point  the  atrio-
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Table  2  Differences  between  dedicated  aspiration  needles.
Company  Model  Size  (G)  Minimum  working
channel  (mm)
Stylet  tip  Compatibility
Olympus Vizishot  1  21,  22  2  Round Olympus,  Fujifilm
Vizishot 2 21,  22 2  Round
Vizishot  Flex 19  2.2  --
Boston Scientific The  Expect  TM 22,  25 2  Round  Olympus,  Pentax,
Fujifilm
Cook Medical Echotip  22,  25  2  Beveled Olympus,  Fujifilm  (with
adaptor),  PentaxEchotip Procore  22  2  Round
Echotip  Procore  25  2  Beveled
Medi-Globe Sonotip Pro  22  2  Round Olympus,  Pentax,
FujifilmSonotip Pro  Flex  22  2  Round
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wentricular  valves  and  the  left  atrium  with  pulmonary  vein
lose  to  the  esophageal  wall.  While  withdrawing  the  scope
lightly  more,  subcarinal  lymph  nodes  (station  7),  especially
he  posterior  group,  are  clearly  visible  (Fig.  4C),  and  to  the
ight,  reflections  from  the  trachea  and  the  proximal  wall
f  the  right  main  bronchus  are  seen,  as  well  as  the  right
ulmonary  artery  in  a  transverse  section.  Further  retreating
he  scope  and  looking  anteriorly  at  the  tracheal  reflections
t  its  lower  part,  slightly  to  the  right,  the  posterior  part  of
he  right  paratracheal  lymph  nodes  (station  4R),  behind  azy-
os  vein,  can  be  found  in  many  cases.  At  this  level,  rotating
he  EUS-B  scope  to  the  left  will  permit  to  detect  the  lower
aratracheal  (station  4L)  and  deeper  aorto-pulmonary  win-
ow  lymph  nodes  (station  5)  between  the  pulmonary  artery
nd  aorta  (‘‘mickey  mouse  effect’’)  (Fig.  4D).  On  the  left,
he  entire  descending  intrathoracic  aorta  can  be  followed
long  the  esophagus,  and  para-aortic  lymph  nodes  (station
)  may  be  visualized  through  the  aortic  arch.  Behind  the
orta,  reflections  from  the  thoracic  spine  are  well  seen.  As
he  EUS-B  scope  is  further  withdrawn,  the  left  subclavian
rtery  and  upper  left  paratracheal  lymph  nodes  (station  2L)
re  identified  on  the  left  side,  and  just  behind  them  the  left
nternal  jugular  vein  is  often  found  (Fig.  4E).  To  the  level
f  the  upper  part  of  the  esophagus,  both  lobes  of  the  thy-
oid  gland  can  be  seen  and  below  them  seldom  mediastinal
ighest  lymph  nodes  (station  1)  can  be  seen.
The  technique  for  needle  biopsy  aspiration  is  similar  to
he  one  performed  for  EBUS-TBNA,  but  often  easier  because
f  the  softness  of  the  esophageal  wall.  On  the  other  hand,
he  EUS-B-NA  seems  to  be  more  difficult  because  of  incorrect
djustment  to  the  esophageal  wall.  Therefore,  the  reach  of
US-B  is  the  same  as  for  EUS:  it  is  possible  to  puncture  the
AG,  left  lobe  of  the  liver,  lymph  node  stations  2L,  4L,  7,  8,
 (Fig.  5)  and  in  specific  situations  the  lower  part  of  station
,  posterior  part  of  station  4R  and  station  1.
afetyPlease  cite  this  article  in  press  as:  Bugalho  A,  et  al.  Pulmonol.
he  intra-esophageal  introduction  of  an  EBUS-scope  and  its
se  for  EUS-B-NA  is  safe.  No  serious  complications  have
een  reported.  Nevertheless,  the  development  of  a  lymph
ode  abscess  after  simultaneous  EBUS-TBNA  was  described
t
d
p
wn  one  subject.13 In  a  systematic  review  of  combined  EUS-
A  and  EBUS-TBNA  for  staging  of  mediastinal  lymph  nodes
n  lung  cancer,  severe  complications  were  reported  in  two
atients  (0.3%),  the  patient  with  the  lymph  node  abscess
nd  a pneumothorax  in  an  additional  patient.41 However,  the
BUS  bronchoscope  is  not  only  thinner,  but  also  sharper  at
he  tip.  This  fact  needs  to  be  considered  when  the  broncho-
cope  is  used  in  the  esophagus.  If  the  esophagus  is  narrowed
r  a  diverticulum  is  present,  but  not  easily  visible  due  to
he  side-view  optic,  there  is  a  significant  risk  of  iatrogenic
leeding  due  to  mucosal  damage  or  even  of  perforation  of
he  esophageal  wall  (Fig.  6).
raining and competency
ndoscopy  is  part  of  the  European  respiratory  curriculum
s  well  as  the  integration  of  knowledge  regarding  thoracic
adiology,  mediastinal  anatomy,  and  lymph  node  map.42
It  makes  sense  to  train  individual  bronchoscopists  in  EBUS
nd  EUS-B  at  the  same  time  and  enable  them  to  perform
omplete  endoscopic  staging  in  one  session  2.43 However,
ven  the  criteria  for  competency  in  EBUS  are  unclear  and  left
o  subjective  judgment  of  trainers.  The  arbitrarily  defined
umber  of  supervised  procedures  does  not  guarantee  that
he  trainee  will  master  the  procedure  in  the  end,  since
very  individual  follows  his  own  learning  curve.44 Hence  the
ocus  should  be  directed  toward  evaluation  of  the  individ-
al’s  performance  and  outcomes  by  predefined  criteria.45
ew  trainees  in  EBUS/EUS-B-NA  should  follow  a  structured
raining  curriculum  consisting  of  simulation-based  training
ollowed  by  supervised  practice  on  patients.2,42,46 Self-
earning  is  no  longer  an  acceptable  method  since  it  inflicts
istress,  causes  potentially  false  therapeutic  decisions,  and
hould  be  therefore  discouraged.47
The  next  important  issue  is  maintaining  competency  after
nitial  EBUS/EUS-B  training.  Diagnostic  yield  can  improve
ith  continuous  practice  and  the  number  of  complications 2018.  https://doi.org/10.1016/j.rppnen.2017.10.004
ends  to  decline.48,49 Furthermore,  there  is  evidence  that
edicated  interventional  pulmonologists  are  more  likely  to
erform  procedures  properly  than  general  pulmonologists
ho  do  not  perform  them  on  the  regular  basis.50
Please  cite  this  article  in  press  as:  Bugalho  A,  et  al.  Pulmonol.  2018.  https://doi.org/10.1016/j.rppnen.2017.10.004
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Figure  4  CT  view  and  EUS-B  view  of  the  main  anatomic  landmarks  (Ao  --  aorta,  D  --  diaphragm,  H  --  heart,  L  --  liver,  LA  --  left
atrium, Lu  --  lung,  PA  --  pulmonary  artery,  SA  --  subclavian  artery,  V  --  vertebra).
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Figure  5  Sagital  view  of  thorax  CT  with  main  acessible  EUS-B
lymph node  stations  (Ao  --  aorta,  PA  --  pulmonary  artery,  LA  --
left atrium,  L  --  liver).
Figure  6  Endoscopic  image  of  the  distal  esophagus  after  EUS-
B-NA shows  a  large  iatrogenic  perforation  of  the  esophageal  wall
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6. Oki M, Saka H, Ando M, Tsuboi R, Nakahata M, Oka S,
et al. Transbronchial vs transesophageal needle aspiration usinglose  to  the  cardia.
uture of EUS-B
US-B  is  a  relatively  recent  method  that  for  which  a  wider
mplementation  and  further  development  are  expected.  So
ar  we  only  have  reports  from  centers  of  expertise,  which
re  promising  and  assure  EUS-B  potential.4,5,32 Therefore,
e  perceive  the  safe  implementation  of  EUS-B  by  previously
rained  EBUS  professionals  in  clinical  practice  as  the  first
tep  in  the  future  of  EUS-B-NA  development.  It  remains  open
ow  this  can  be  executed  but  focused  additional  training
ith  collaboration  of  EUS  specialists  is  perhaps  the  logi-
al  solution.  Additionally,  data  from  further  trials  should  be
ublished,  to  gain  more  evidence  about  feasibility,  diagnos-
ic  yield,  and  complications.
Further  equipment  development  is  heading  toward  thin-
er  and  more  flexible  EBUS  scopes,  with  extended  range  ofPlease  cite  this  article  in  press  as:  Bugalho  A,  et  al.  Pulmonol.
isibility  and  biopsy  possibilities  in  the  lungs.51 The  same
nstruments  need  to  be  re-evaluated  in  the  upper  gastro- PRESS
A.  Bugalho  et  al.
ntestinal  tract  to  judge  whether  their  performance  matches
he  recent  EBUS-bronchoscopes.
EBUS  and  EUS-NA  offer  the  most  accurate  diagnosis
f  metastatic  lymph  node  infiltration,  but  the  accuracy
epends  on  the  appropriate  selection  of  the  lymph  node
nd  targeting  the  suspicious  area  within  the  node.52 The
uropean  guidelines  for  elastography  suggest  that  EUS-
lastography  adds  information  to  the  B-mode  evaluation  of
ymph  nodes  and  can  accurately  guide  needle  biopsy  in  the
tiffer  part  of  a  suspicious  lesion.53 EUS-B  elastography  was
easible  and  reproducible  in  parallel  with  the  EBUS  elas-
ography,  when  the  same  lymph  nodes  were  evaluated.54
erhaps,  such  data  would  be  even  more  interesting  in  the
AG,  which  currently  remains  for  future  evaluation.
onclusion
t  took  longer  for  chest  physicians  to  start  performing  EUS-B
ompared  to  EBUS  and  not  all  institutions  do  the  procedure
n  a  routine  basis.
The  use  of  EUS-B-NA  for  cytological  diagnosis  of  malig-
ant  and  benign  diseases  is  feasible  and  safe.  The  results
f  EUS-B-NA  are  comparable  to  just  EUS-NA  and  a  com-
ined  approach  with  EBUS-TBNA  is  recommended  for  lung
ancer  staging  since  it  increases  diagnostic  yield  and  accu-
acy.  Chest  physicians  should  execute  EUS-B  after  proper
tructured  training.  New  indications,  scientific  data  and
quipment  developments  are  bound  to  happen  over  the
oming  years.
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